HEADER ANTIMICROBIAL PROTEIN 01-MAR-18 6CL3 TITLE LYETXI-B, A SYNTHETIC PEPTIDE DERIVED FROM LYCOSA ERYTHROGNATHA SPIDER TITLE 2 VENOM, SHOWS POTENT ANTIBIOTIC ACTIVITY, IN VITRO AND IN VIVO COMPND MOL_ID: 1; COMPND 2 MOLECULE: TOXIN LYETX 1; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: LYCOSA ERYTHROGNATHA; SOURCE 4 ORGANISM_COMMON: SPIDER; SOURCE 5 ORGANISM_TAXID: 332789 KEYWDS ANTIMICROBIAL PEPTIDE, ANTIMICROBIAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR M.E.DE LIMA,P.V.DOS REIS,J.M.RESENDE,R.M.VERLY REVDAT 1 30-MAY-18 6CL3 0 JRNL AUTH P.V.M.REIS,D.BOFF,R.M.VERLY,M.N.MELO-BRAGA,M.E.CORTES, JRNL AUTH 2 D.M.SANTOS,A.M.C.PIMENTA,F.A.AMARAL,J.M.RESENDE,M.E.DE LIMA JRNL TITL LYETXI-B, A SYNTHETIC PEPTIDE DERIVED FROMLYCOSA JRNL TITL 2 ERYTHROGNATHASPIDER VENOM, SHOWS POTENT ANTIBIOTIC JRNL TITL 3 ACTIVITYIN VITROANDIN VIVO. JRNL REF FRONT MICROBIOL V. 9 667 2018 JRNL REFN ESSN 1664-302X JRNL PMID 29681894 JRNL DOI 10.3389/FMICB.2018.00667 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6CL3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-MAR-18. REMARK 100 THE DEPOSITION ID IS D_1000232943. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 293 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : NOT APPLICABLE REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 2 MM LYETXI-B, 20 MM PHOSPHATE REMARK 210 BUFFER, 1 MM DSS, TFE-D2/H2O (60: REMARK 210 40%, V/V) REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D 1H-1H NOESY; REMARK 210 2D 1H-13C HSQC; 2D 1H-15N HMQC REMARK 210 SPECTROMETER FIELD STRENGTH : 600.043 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III 600 REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRVIEW, NMRPIPE, TOPSPIN, REMARK 210 MOLMOL, TALOS, X-PLOR NIH REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-10 REMARK 465 RES C SSSEQI REMARK 465 ACE A 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HD3 LYS A 7 H PHE A 8 1.34 REMARK 500 O GLY A 10 H GLY A 14 1.47 REMARK 500 O ALA A 5 H LEU A 9 1.54 REMARK 500 O LYS A 7 H LYS A 11 1.59 REMARK 500 O LEU A 9 H LEU A 13 1.60 REMARK 500 O PHE A 8 H ASN A 12 1.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30424 RELATED DB: BMRB REMARK 900 LYETXI-B, A SYNTHETIC PEPTIDE DERIVED FROM LYCOSA ERYTHROGNATHA REMARK 900 SPIDER VENOM, SHOWS POTENT ANTIBIOTIC ACTIVITY, IN VITRO AND IN VIVO DBREF 6CL3 A 1 24 UNP C0HJU9 LYT1_LYCER 1 25 SEQADV 6CL3 ACE A 0 UNP C0HJU9 ACETYLATION SEQADV 6CL3 A UNP C0HJU9 HIS 16 DELETION SEQADV 6CL3 NH2 A 25 UNP C0HJU9 AMIDATION SEQRES 1 A 26 ACE ILE TRP LEU THR ALA LEU LYS PHE LEU GLY LYS ASN SEQRES 2 A 26 LEU GLY LYS LEU ALA LYS GLN GLN LEU ALA LYS LEU NH2 HET NH2 A 25 3 HETNAM NH2 AMINO GROUP FORMUL 1 NH2 H2 N HELIX 1 AA1 ILE A 1 LEU A 24 1 24 LINK C LEU A 24 N NH2 A 25 1555 1555 1.31 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1